Adcorp

Hospital

Adcock Ingram Critical Care is a leading supplier of hospital and critical care products offered through multiple portfolios and across wide-ranging customer channels.

OVERVIEW

The business is a fully integrated operation which spans regulatory, research and development, manufacturing, marketing, sales and distribution. Adcock Ingram Critical Care not only commercialises a broad product offering but manufactures an extensive range in its unique dual process factory which comprises a comprehensive plastics extrusion plant and a fully accredited pharmaceuticals manufacturing facility.

The Adcock Ingram Critical Care portfolio includes:

•	renal therapies across all the key dialysis modalities, including renal pharmaceuticals
•	intravenous solutions, both large and small volume parenterals
•	transfusion therapies for the collection and storage of blood
•	infusion systems, invasive diagnostics and nutrition
•	bioscience and specialised pharmaceuticals, which include many newly added formulations as well as holding a promising pipeline.

BUSINESS FOCUS

The business is a fully integrated operation which spans regulatory, research and development, manufacturing, marketing, sales and distribution. Adcock Ingram Critical Care not only commercialises a broad product offering but manufactures an extensive range in its unique dual process factory which comprises a comprehensive plastics extrusion plant and a fully accredited pharmaceuticals manufacturing facility.

The Adcock Ingram Critical Care portfolio includes:

•	Uncompromising attention to customer service in the areas of supply, delivery and communications
•	Maintaining and growing market leading positions in both established as well as newly penetrated therapy areas
•	Expansion into adjacent categories through licensing, partnerships and strategic alliances
•	Maximising operations with intense focus on yield, wastage, efficiencies and automation
•	Focus on product mix across and within portfolios, thus supporting sustainable and profitable growth
•	Maintaining close relationship with Government to support national demand
•	Maintaining close relationship with all stakeholders to build trust, demonstrate commitment and deliver on expectations.

A broader segmental definition with credentials can be defined as follows:

		Renal			Medicine Delivery			Transfusion Therapies			Bioscience; and Specialised Pharmaceuticals
		• In partnership with Netcare, owns National Renal Care (NRC) which remains the largest service provider for renal care in South Africa. • Critical Care remains the largest supplier of goods and services within:   – Peritoneal Dialysis (PD), including a uniquely modelled Renal Home Delivery Service (RHDS) – Haemodialysis (HD) – Continuous Renal Replacement Therapy (CRRT) – Renal Pharmaceuticals.			• Largest supplier of large volume parenterals (LVP’s) in South Africa • Market leader in regional anaesthesia, and sterile water for irrigation (pour water) • Has a comprehensive range of SVP’s across multiple therapeutic areas including anti-infectives, oncology, anti-emetics, respiratory and hypnotics.			• Fully integrated manufacturing facility for the manufacture of blood bags and tubing • Largest supplier of free flowing leucodepletion sets and blood bags in South Africa • Largest supplier to SANBS (South African National Blood Services) with which it has enjoyed a relationship for more than 50 years.			• A leader in the supply of product for Haemophilia • A leading supplier of speciality pharmaceuticals including sodium polystyrene and one alpha hydroxylase • Has established a host of newly formed strategic alliance relationships over the 2016 period which will bring participation in several new therapy areas including:   – Oral and injectable analgesia – Patient controlled analgesia – Oncology, and – Anaemia.